DNAnexus, UPMC, Sutter Health Launch Clinico-Genomic MS Precision Medicine Study

Clinico-genomic research study aims to improve personalized treatments for people with multiple sclerosis DNAnexus, UPMC, and Sutter Health network said today they have launched a...

Sophia Genetics Gains CE-IVD Marking for Solid Tumor Solution

Sophia Genetics has obtained the CE-IVD marking for its Solid Tumor Solution (STS), a molecular diagnostic application designed to precisely detect and characterize all...

Genomics Medicine Ireland Opens Dublin Clinic for Precision Medicine Research

Genomics Medicine Ireland (GMI), the recently-acquired Irish subsidiary of WuXi NextCode, said today it has opened a research clinic in Dublin’s City Centre hub,...
Colon cancer. Cancer attacking cell. Colon disease concept

CRC Evades Immunotherapies by Regulating Expression of Cell Surface Molecule

CRC tumors can switch off expression of a cell surface molecule that is a key target of immunotherapy, thus preventing the treatment from working.

Genomenon, Parabricks Offer Products Via Google Cloud Platform

A pair of companies specializing in applying computing to genomics said today they will make their products available via Google Cloud Platform, through partnerships...
Projections for the growth of the liquid biopsy market range as low as $1 billion by 2020

10 Liquid Biopsy Companies in the Money

10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.

Five-Year Super Successes in Genomics and Precision Medicine

Multidimensional, computationally rich approaches represent the next wave of innovation, taking personalized medicine to the next level, while demanding more of practitioners, who in...
CRISPR technology

Top 600 Cancer Drug Targets Ranked Using CRISPR

Researchers from the Wellcome Sanger Institute, GlaxoSmithKline, EMBL-EBI, and Open Targets conducted one of the largest CRISPR screens of cancer genes to date.
Prostate cancer cells, illustration

Helomics, SpeciCare Enter Live Tumor Tissue Precision Cancer Care Collaboration

Helomics will provide CRO services and its D-CHIP artificial intelligence (AI) platform for a functional precision medicine study called PIONEER sponsored by SpeciCare.
Source: freestylephoto/Getty Images

20 Molecular Diagnostics Companies to Watch

Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
Scroll Up